TRPX Research and Charts

TRPX - Therapix Biosciences Ltd ADR (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data )

Last	Change ⇓ 0.00 (%)	Volume 0
	Open	High	Low

8EMA (Daily) 0.00	40EMA (Daily)	50EMA (Daily)	STO (Daily)	MACD Hist (Daily)
8EMA (Weekly) 0.278	40EMA (Weekly) 0.86	50EMA (Weekly) 1.09	STO (Weekly) 2.722	MACD Hist (Weekly) 0.002


Company Profile
Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company is developing THX-110 targeted to the treatment of Tourette Syndrome and THX-130 targeted to the high value and under-served market of mild cognitive impairments.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.